Uti Clinical Trials
3 recruiting trials for Uti. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Uti clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by University of Texas Southwestern Medical Center (1), Sohag University (1), Benaroya Research Institute (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is D-Mannose (dietary_supplement, 1 trial), followed by Placebo, urinary catheterization.
Track Uti trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
A Trial of D-mannose for the Prophylaxis of Recurrent Urinary Tract Infections
A randomized, double-blind, placebo-controlled, 12-month study to determine the effectiveness of D-mannose (2g daily) supplementation in rUTI (recurrent urinary tract infection)...
Value of Infection Control Programs on Infection Associated with Urinary Tract Catheterization in Sohag University...
The aim of this study is to evaluate the effectiveness of an infection control program implemented at Sohag University Hospital in reducing the incidence of catheter-associated...
Antibiotic Usage Prior to OnabotulinumtoxinA Injection
Intradetrusor injection of onabotulinumtoxinA, which is performed through a cystoscopic procedure, has been demonstrated to be efficacious in the treatment of both neurogenic and...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Uti, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Uti, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Uti, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.